Navigation Links
DePuy ASR Lawsuits Move Forward in New Jersey, With Scheduling of Next Case Management Conference, Bernstein Liebhard LLP Reports
Date:11/9/2013

New York, New York (PRWEB) November 09, 2013

DePuy ASR lawsuits (http://www.depuy-asr-hip-recall.com/) stemming from the 2010 DePuy ASR hip recall continue to move forward in courts throughout the U.S., Bernstein Liebhard LLP reports. According to court documents filed in New Jersey’s Bergen County Superior Court, the next Case Management Conference in the multicounty litigation established for DePuy ASR recall claims has been scheduled for November 21, 2013 at 11:00 a.m. Just over 650 DePuy ASR lawsuits are pending in the New Jersey proceeding. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)

“Our Firm continues to hear from alleged victims of the DePuy ASR recall on a regular basis, and we are representing numerous clients in lawsuits that have been filed in the New Jersey litigation, as well as in the federal proceeding underway in Ohio. We are pleased with the progress of these lawsuits so far,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of DePuy ASR hip recipients. The Firm continues to offer free legal evaluations to individuals who allegedly experienced serious complications related to the DePuy ASR recall.

DePuy ASR Recall Litigation
Court documents indicate that more than 11,500 DePuy ASR lawsuits have been filed in courts around the country since the metal-on-metal hip implants were recalled in August 2010. More than 8,300 of these claims are pending in the federal multidistrict litigation underway in U.S. District Court, Northern District of Ohio. That litigation’s first bellwether trial was scheduled to begin in September, but was postponed for up to 90 days. It has yet to be rescheduled. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

Earlier this year, trials for DePuy ASR lawsuits did commence at the state court level. In March, a plaintiff was awarded more than $8 million after a Los Angeles Superior Court jury found that the hip implant was defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County)

Court documents filed in California’s San Francisco Superior Court indicate that a settlement was reached last month that resolves claims in the DePuy ASR lawsuit that had been selected for that state litigation’s first bellwether trial. The terms of the settlement have not been disclosed. (Ottman v. Johnson & Johnson Services, et al., No. CGC-12-517391;Calif. Super. Ct., San Francisco Cty.)

According to a recent report from Bloomberg.com, several other important trials are scheduled to begin in the next several months in DePuy ASR recall litigations underway in Illinois, Florida and California.*

DePuy ASR hip recipients who allegedly suffered serious complications related to the DePuy ASR recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. Learn More about filing a DePuy ASR lawsuit by visiting Bernstein Liebhard LLP’s website. Free case reviews may also be obtained by calling 800-511-5092.

*bloomberg.com/news/2013-08-21/j-j-said-to-weigh-3-billion-settlement-of-its-hip-implant-cases.html

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuy-asr-hip-recall.com/

Read the full story at http://www.prweb.com/releases/depuy-asr-recall/depuy-asr-lawsuit/prweb11318092.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Impending Metal-on-Metal Hip Ban in UK Hospitals
2. New Case Management Order in New Jersey DePuy ASR Recall Litigation Extends Discovery to June 2014, More than 650 Metal Hip Lawsuits Filed in Consolidated Proceeding
3. DePuy Hip Settlement News: Rottenstein Law Group LLP Reports on Metal-on-Metal Hip Replacement Updates
4. DePuy Pinnacle Lawsuits Stayed in Federal Litigation Pending Completion of First Bellwether Trials, Bernstein Liebhard LLP Reports
5. DePuy ASR Lawsuits Move Forward in New Jersey, as Bernstein Liebhard LLP Notes Upcoming Pretrial Conference
6. DePuy Pinnacle Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pinnacle Hip Litigation
7. DePuy ASR Lawsuit: First Bellwether Trial in Federal DePuy ASR Recall Litigation Postponed For Up To 90 Days, Bernstein Liebhard LLP Reports
8. DePuy Orthopaedics Inc.’s Multidistrict Litigation Update: First Bellwether Trial to Commence Within 90 Days, Parker Waichman LLP Reports
9. First Bellwether Trial in Federal DePuy ASR Lawsuit Litigation Scheduled to Begin after Two-Week Postponement
10. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Certification of DePuy ASR Recall Class Action Lawsuit in Canada
11. DePuy ASR Hip Lawsuit News: Calif. Judge to Determine If Metal-On-Metal Case Will Go to Trial, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: